These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16765820)

  • 1. Clinical trials in children--How are they implemented?
    Hirtz DG; Gilbert PR; Terrill CM; Buckman SY
    Pediatr Neurol; 2006 Jun; 34(6):436-8. PubMed ID: 16765820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues in the design of clinical trials for safety in HIV-infected children.
    Lindsey JC; Kline MW
    Pediatr AIDS HIV Infect; 1996 Apr; 7(2):69-82. PubMed ID: 11361484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the independence of data monitoring committee in adaptive design clinical trials.
    Chow SC; Corey R; Lin M
    J Biopharm Stat; 2012; 22(4):853-67. PubMed ID: 22651119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should statisticians reporting to data monitoring committees be independent of the trial sponsor and leadership?
    Ellenberg SS; George SL
    Stat Med; 2004 May; 23(10):1503-5. PubMed ID: 15122727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817
    [No Abstract]   [Full Text] [Related]  

  • 6. Playing safe and preserving integrity: making the FDA model work.
    Wittes J
    Stat Med; 2004 May; 23(10):1523-5. PubMed ID: 15122731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The independent statistician for data monitoring committees.
    DeMets DL; Fleming TR
    Stat Med; 2004 May; 23(10):1513-7. PubMed ID: 15122729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the data safety and monitoring board in an international trial.
    NIMH Collaborative HIV/STD Prevention Trial
    AIDS; 2007 Apr; 21 Suppl 2():S99-102. PubMed ID: 17413269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it.
    O'Neill RT; Temple R
    Clin Pharmacol Ther; 2012 Mar; 91(3):550-4. PubMed ID: 22318615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test panels no better than internal review.
    Dickey C
    Nat Med; 2003 Jan; 9(1):7-8. PubMed ID: 12514702
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety panel backs principle of gene-therapy trials.
    Check E
    Nature; 2002 Dec; 420(6916):595. PubMed ID: 12478252
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacoepidemiology 101: data monitoring committees in the post-marketing approval setting.
    Lilienfeld DE
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):381-5. PubMed ID: 15170767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in clinical trial design: stopping a trial early and the large and simple trial.
    Thom EA; Klebanoff MA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):619-25. PubMed ID: 16150252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from adult stroke trials.
    Pavlakis SG; Sacco R; Levine SR; Meschia JF; Palesch Y; Tilley BC; Adams HP
    Pediatr Neurol; 2006 Jun; 34(6):446-9. PubMed ID: 16765822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety in paediatric clinical trials--a 7-year review.
    Sammons HM; Gray C; Hudson H; Cherrill J; Choonara I
    Acta Paediatr; 2008 Apr; 97(4):474-7. PubMed ID: 18307556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric stroke initiatives and preliminary studies: What is known and what is needed?
    Sofronas M; Ichord RN; Fullerton HJ; Lynch JK; Massicotte MP; Willan AR; deVeber G
    Pediatr Neurol; 2006 Jun; 34(6):439-45. PubMed ID: 16765821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The other side of clinical trial monitoring; assuring data quality and procedural adherence.
    Williams GW
    Clin Trials; 2006; 3(6):530-7. PubMed ID: 17170037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring the safety of participants in randomised clinical trials: basis and methods].
    Tijssen JG
    Ned Tijdschr Geneeskd; 2008 Mar; 152(12):674-8. PubMed ID: 18438062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.